The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 13, 2021
The FDA has approved Eli Lilly and Company's Verzenio® (abemaciclib), in combination with endocrine therapy (tamoxifen or an aromatase inhibitor), for...
read more
Wednesday, October 13, 2021
Takeda announced that the FDA Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously to recommend use of maribavir (TAK-620) for the ...
read more
Wednesday, October 13, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the FDA ...
read more
Wednesday, October 13, 2021
Merck announced the submission of an Emergency Use Authorization (EUA) application to the FDA for molnupiravir, an investigational oral antiviral ...
read more
Wednesday, October 13, 2021
Genentech announced that gantenerumab, an anti-amyloid beta antibody developed for subcutaneous administration, has been granted Breakthrough Therapy ...
read more
Wednesday, October 13, 2021
Tezepelumab is being developed by AstraZeneca in collaboration with Amgen and is under Priority Review for patients with asthma in the US. The FDA ...
read more
Wednesday, October 13, 2021
ChemoCentryx announced that the FDA has approved TAVNEOS (avacopan), an orally administered selective complement 5a receptor inhibitor, as an ...
read more
Wednesday, October 13, 2021
Agenus Inc, an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to ...
read more
Thursday, October 14, 2021
Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, ...
read more
Thursday, October 14, 2021
Merck announced that the FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy, with or without bevacizumab, for the ...
read more
Thursday, October 14, 2021
Otsuka and H. Lundbeck report that the FDA has accepted a Supplemental New Drug Application (sNDA) for the treatment of schizophrenia in adolescents ...
read more
Thursday, October 14, 2021
Regeneron Pharmaceuticals announced that the FDA has accepted for priority review a Biologics License Application (BLA) for REGEN-COV® (casirivimab ...
read more
Wednesday, October 20, 2021
FDA has approved ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose. ZIMHI is administered using a single-dose,...
read more
Wednesday, October 20, 2021
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody ...
read more
Wednesday, October 20, 2021
Seqirus, a global leader in influenza prevention, and a business of CSL Limited (ASX: CSL), announced that the FDA approved FLUCELVAX® QUADRIVALENT (...
read more